BDNF - brain derived neurotrophic factor Gene
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 701245
BDNF Products (5)
| mRNA | Protein | Name |
|---|---|---|
| XM_015114599.2 | XP_014970085.1 | brain-derived neurotrophic factor isoform X2 |
| XM_015114601.2 | XP_014970087.1 | brain-derived neurotrophic factor isoform X3 |
| XM_015114600.2 | XP_014970086.1 | brain-derived neurotrophic factor isoform X3 |
| XM_015114602.2 | XP_014970088.1 | brain-derived neurotrophic factor isoform X4 |
| XM_015114598.2 | XP_014970084.1 | brain-derived neurotrophic factor isoform X1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
brain-derived neurotrophic factor |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0531 | Triflusal | 99.56% | Unkown |
Clinical Phase
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-B1618 | Corticosterone | Agonist | 99.77% | Phase 3 |
| HY-16728 | Rapastinel | 99.78% | Phase 3 | |
| HY-139897 | CX 717 | Agonist | 99.95% | Phase 2 |
| HY-110255 | AZD 2066 | 99.8% | Phase 2 | |
| HY-110255A | AZD 2066 hydrate | ≥99.0% | Phase 2 | |
| HY-120251A | Leteprinim potassium | Inhibitor | 99.0% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(87)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-W013372 | 7,8-Dihydroxyflavone | 99.74% | Unkown | |
| HY-106224B | Orexin A (human, rat, mouse) acetate | Agonist | 99.53% | Unkown |
| HY-P1178 | Cyclotraxin B | Inhibitor | 99.78% | Unkown |
| HY-18939 | N6-Cyclohexyladenosine | 99.98% | Unkown | |
| HY-114384B | Mefluleucine hydrochloride | Activator | 98.0% | Unkown |
| HY-120657 | 9-PAHSA | 99.88% | Unkown | |
| HY-N2125 | Parishin C | Agonist | 99.24% | Unkown |
| HY-100115 | TA-02 | Inhibitor | 99.44% | Unkown |
| HY-N2055 | Kaempferol 3-O-sophoroside | 99.41% | Unkown | |
| HY-N2038 | 3,5,6,7,8,3',4'-Heptemthoxyflavone | Inhibitor | 99.86% | Unkown |
| HY-N0392 | Polygalasaponin F | 99.85% | Unkown | |
| HY-P1146 | Semax | Inhibitor | 99.56% | Unkown |
| HY-110166 | PD 90780 | 98.83% | Unkown | |
| HY-N7981 | Pratensein | Inhibitor | 99.92% | Unkown |
| HY-13999 | Amdiglurax | 99.53% | Yes | |
| HY-122742 | HBT1 | 99.73% | Unkown | |
| HY-W747599 | Ganglioside GQ1b (bovine) sodium | ≥98.0% | Unkown | |
| HY-124591 | TC-2153 | Inhibitor | 98.19% | Unkown |
| HY-14569 | CDPPB | 98.01% | Unkown | |
| HY-W044525 | Phyllodulcin | Inhibitor | 99.75% | Unkown |
| HY-153383 | PDCD4-IN-1 | Inhibitor | 99.41% | Unkown |
| HY-16728B | Rapastinel Trifluoroacetate | 98.0% | Unkown | |
| HY-W749694 | Cannflavin B | Inhibitor | 98.36% | Unkown |
| HY-N2736 | 3′,4′,7-Trihydroxyflavone | Inhibitor | 99.04% | Unkown |
| HY-P1146A | Semax acetate | Inhibitor | 99.39% | Unkown |
| HY-121793 | Roemerine | Inhibitor | 99.89% | Unkown |
| HY-111527 | PPZ2 | 99.92% | Unkown | |
| HY-173025 | Nurr1 agonist 12 | Agonist | 99.62% | Unkown |
| HY-N6076 | Tenuifoliside A | Inhibitor | 98.09% | Unkown |
| HY-N1414A | 3′,6-Disinapoylsucrose | Inhibitor | 98.88% | Unkown |
| HY-132993 | Hcyb1 | Inhibitor | 98.20% | Unkown |
| HY-142026 | Vitisin A | 96% | Unkown | |
| HY-N1414 | (E)-3',6-Disinapoylsucrose | 99.59% | Unkown | |
| HY-N3097 | Pellitorine | 99.84% | Unkown | |
| HY-N8693 | Withanoside IV | 98.47% | Unkown | |
| HY-RS16220 | Bdnf Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-102091 | (2R,4R)-APDC | Agonist | / | Unkown |
| HY-102091A | (2R,4R)-APDC hydrate | Agonist | 98.0% | Unkown |
| HY-13999A1 | Amdiglurax phosphate | Activator | 99.75% | Unkown |
| HY-160921 | Capeserod | Agonist | 98.66% | Unkown |
| HY-172876 | FLY26 | 99.66% | Unkown | |
| HY-179390 | KMCA-0011 | Antagonist | 99.88% | Unkown |
| HY-N2125R | Parishin C (Standard) | Agonist | 98.88% | Unkown |
| HY-N3298 | Meranzin | Modulator | 98.0% | Unkown |
| HY-RS01460 | BDNF Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W770410 | 9-PAHSA-13C4 | 99.9% | Unkown | |
| HY-144026S | 9-PAHSA-d9 | / | Unkown | |
| HY-169964 | TSPO/Carbonic Anhydrase Modulator 1 | Modulator | / | Unkown |
| HY-120251 | Leteprinim | Inhibitor | / | Unkown |
| HY-120306 | HHL-6 | Inhibitor | / | Unkown |
| HY-121012 | (rac)-AG-205 | / | Unkown | |
| HY-123222 | CGP 56999 | Antagonist | / | Unkown |
| HY-123439 | FTY720-C2 | Inhibitor | 99.64% | Unkown |
| HY-138967 | BRF110 | / | Unkown | |
| HY-13906 | Largazole | Inhibitor | / | Unkown |
| HY-139806 | SRA880 free base | Inhibitor | / | Unkown |
| HY-146523 | TRK-IN-17 | Inhibitor | / | Unkown |
| HY-146524 | TRK-IN-18 | Inhibitor | / | Unkown |
| HY-157792 | Antidepressant agent 6 | Antagonist | / | Unkown |
| HY-16728A | Rapastinel acetate | / | Unkown | |
| HY-174337 | PX5–9 | / | Unkown | |
| HY-174339 | Neuroprotective agent 12 | / | Unkown | |
| HY-174419 | TFSeB | / | Unkown | |
| HY-175483S | TrkB activator-1 | Activator | / | Unkown |
| HY-178153 | BPAM363 | Modulator | / | Unkown |
| HY-179337 | PDE2-IN-1 | / | Unkown | |
| HY-181998 | CN016 | Inhibitor | / | Unkown |
| HY-184011 | SERT-IN-4 | / | Unkown | |
| HY-D2970 | Golgi-P | / | Unkown | |
| HY-E70870 | TRKB(NTRK2) Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-N0392R | Polygalasaponin F (Standard) | Inhibitor | / | Unkown |
| HY-N18209 | 4-Hydroxy-3-butylphthalide | / | Unkown | |
| HY-N20637 | Polygalasaponin XXXII | Activator | / | Unkown |
| HY-N4161 | Euparin | Inhibitor | 99.0% | Unkown |
| HY-P11092 | TLQP-62 (mouse,rat) | / | Unkown | |
| HY-P1178A | Cyclotraxin B TFA | Inhibitor | / | Unkown |
| HY-110255B | AZD-2066 hydrochloride | / | Unkown | |
| HY-120657S | 9-PAHSA-d4 | / | Unkown | |
| HY-120657S1 | 9-PAHSA-d31 | 99.00% | Unkown | |
| HY-124503 | Longanlactone | Activator | / | Unkown |
| HY-164461 | AZD6918 | Inhibitor | / | Unkown |
| HY-167836 | BNN-20 | Activator | / | Unkown |
| HY-181588 | NR4A agonist-2 | Agonist | / | Unkown |
| HY-N11872 | Suffruticosol A | Activator | / | Unkown |
| HY-N7773 | Hibiscetin | / | Unkown | |
| HY-RS22932 | Bdnf Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W101298S | (Leu-13C6,15N)-Ile-OH TFA | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991413 | ZEB85 | Activator | 96.3985% | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | BDNF | NCBI | NCBI:627 |
| Canis familiaris | BDNF | NCBI | NCBI:403461 |
| Mus musculus | BDNF | NCBI | NCBI:12064 |
| Rattus norvegicus | BDNF | NCBI | NCBI:24225 |